Journal
CLINICAL AND EXPERIMENTAL NEPHROLOGY
Volume 16, Issue 2, Pages 214-220Publisher
SPRINGER
DOI: 10.1007/s10157-011-0568-0
Keywords
Renin-angiotensin system; Angiotensin II; TGF-beta; Tissue fibrosis; Glomerulosclerosis
Categories
Funding
- Ministry of Education, Science, Sports and Culture of Japan
- Grants-in-Aid for Scientific Research [23591570] Funding Source: KAKEN
Ask authors/readers for more resources
Recently, there has been a paradigm shift away from an emphasis on the role of the endocrine (circulating) renin-angiotensin system (RAS) in the regulation of the sodium and extracellular fluid balance, blood pressure, and the pathophysiology of hypertensive organ damage toward a focus on the role of tissue RAS found in many organs, including kidney. A tissue RAS implies that RAS components necessary for the production of angiotensin II (Ang II) reside within the tissue and its production is regulated within the tissue, independent of the circulating RAS. Locally produced Ang II plays a role in many physiological and pathophysiological processes such as hypertension, inflammation, oxidative stress, and tissue fibrosis. Both glomerular and tubular compartments of the kidney have the characteristics of a tissue RAS. The purpose of this article is to review the recent advances in tissue RAS research with a particular focus on the role of the glomerular RAS in the progression of renal disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available